The Innovative Medicines Initiative (IMI) project PREMIER aims to develop a centralised, user-friendly digital assessment system accessible for all relevant stakeholders. PREMIER will also explore options to incorporate environment considerations earlier in the drug development process to inform drug design and to reduce the need of animal testing. ECT is involved in this project as […]
The Innovative Medicines Initiative (IMI) project ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER) aims to develop a centralised, user-friendly and transparent digital assessment system accessible for all relevant stakeholders such as regulatory agencies, pharmaceutical industry, water managers and environmental non-governmental organisations. Furthermore, PREMIER will explore the options to incorporate environment considerations earlier […]
The SETAC North America 40th Annual Meeting takes place in Toronto (Canada) from 3 – 7 November 2019. ECT contributes with the following presentation:
The aim of this project is to develop and evaluate concepts for a risk assessment of wastewater effluents taking into account the joint effects of chemicals, which are not completely eliminated in the wastewater treatment process. The focus is on pharmaceutical residues and industrial chemicals, particularly those that are frequently detected in effluents. The predictability […]
In a long-term experiment run by Agriculture & Agri-Food Canada, the fate of pharmaceuticals and other substances contained in biosolids was followed after farm-scale application to agricultural land on an experimental field site in Ottawa. In the context of this experiment, ECT followed the development of nematode and enchytraeid communities over several years after the […]
The widespread detection of a large variety of pharmaceuticals in the environment has raised concern about the potential impact of these bioactive substances on the environment. The overall aim of ERAPharm was to advance existing knowledge and methods for the environmental risk assessment of pharmaceuticals. Within the three years of the project, the impact of […]
ECT Oekotoxikologie GmbH was founded as a privately owned, independent enterprise in 1993, and joined the SynTech Research Group in November 2021.
In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.
Find us at
ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Phone: +49 6145 9564-0
Fax: +49 6145 9564-99